Monday, March 26, 2012

Travel Medicine


Why should travelers see a physician before they leave on a trip?

Travelers should see a physician before leaving for a trip if
  • they are going to developing countries,
  • they are visiting sites that are not on the usual tourist routes or traveling to high altitudes,
  • they have chronic diseases that could be affected by travel,
  • they are visiting countries that require vaccinations before they allow travelers to enter the country.
The goal of a pre-travel medical evaluation is to help travelers protect themselves against (1) common diseases that may be mild but that will disrupt their trip, and (2) less common diseases that may be serious or even fatal. All travelers need to be up to date on routine vaccines they would normally get if they were not traveling. For example, an annual influenza vaccination (flu shot) is recommended if traveling during influenza season. Travelers should also be up to date on tetanus vaccines. If a tetanus booster is needed, your physician may elect to use the Tdap vaccine that also provides continuing protect against adult pertussis. No vaccinations are required for re-entry into the United States after travel.

What diseases occur in travelers, and how can disease be prevented?

Travelers can pick up infections from contaminated food or water, from insect bites, animal bites, or from other people. Vaccinations, medications, and simple precautions can reduce or eliminate the risk of many of these travel-related infections. While infections are the most common problem for travelers, it is important to remember that the most common cause of death in travelers is motor vehicle accidents. Be sure to look both ways before crossing the street, don't get in the car if the driver is drunk, and use seat belts if available both at home and when traveling.
This review will cover diseases commonly encountered by travelers or those for which vaccinations are recommended. For a more complete discussion, please refer to the CDC travel medicine web site (http://www.cdc.gov).

Optic Neuritis


What is optic neuritis?

Optic neuritis is inflammation of the optic nerve, the structure that connects the eye to the brain. The optic nerve consists of nerve tracts (axons) that originate in the retina of each eye. The optic nerve carries visual information from the retina to the nerve cells in the brain stem, where the information is relayed to the area of the brain that recognizes vision (the occipital cortex).
Optic neuritis can occur in children or adults and may involve either one or both optic nerves. Optic neuritis typically affects young adults ranging from 18-45 years of age, with a mean age of 30-35 years. There is a strong female predominance. The annual incidence is approximately 5/100,000, with a total prevalence estimated to be 115/100,000.

Valley Fever (Coccidioidomycosis)


What is valley fever (coccidioidomycosis)?

Valley fever (coccidioidomycosis) is a disease caused by fungi (Coccidioides immitis and C. posadasii species) that in about 50%-75% of normal (not immunocompromised) people causes either no symptoms or mild symptoms and those infected never seek medical care; when symptoms are more pronounced, they usually present as lung problems (cough, shortness of breath, sputum production, fever, and chest pains). The disease can progress to chronic or progressive lung disease and may even become disseminated to the skin, brain (meninges), skeleton, and other body areas. The disease can also infect many animal types (for example, dogs, cattle, otters, and monkeys).
Most microbiologists and infectious disease physicians prefer the name coccidioidomycosis because the word describes the disease as a specific fungal disease, and this term may replace valley fever in the future. This disease has several commonly used names (valley fever, San Joaquin Valley fever, California valley fever, acute valley fever, and desert fever). Other names get confused with valley fever (for example, rift or African valley fever, which is caused by a virus).
Coccidioidomycosis was first noted in the 1890s in Argentina; tissue biopsies of people with the disease showed pathogens that resembled coccidia (protozoa). During 1896-1900, investigators learned the disease was caused by a fungus, not protozoa, so the term "mycosis" was eventually added to "coccidia." The disease is often noted to occur in outbreaks, usually when soil is disturbed and dust arises, and when groups of people visit an endemic region (such as San Joaquin Valley or Bakersfield, California, and Tucson, Arizona, or parts of southern New Mexico or west Texas) during late summer and early fall. The disease is not transmitted person to person; it is acquired from the environment via contaminated soil and dust. About 100,000 cases are diagnosed each year in the U.S.

What causes valley fever (coccidioidomycosis)?

Coccidioidomycosis is caused by two species of fungi, Coccidioides immitis and Coccidioides posadasii. Both are dimorphic (having mycelial and spore phases), almost always acquired through the respiratory tract by inhalation. When viewed microscopically, the mycelial form found in the soil has arthroconidia (barrel-shaped asexual spores) attached to non-spore-forming rectangular mycelium cells, usually alternating in a line. Once the arthroconidia are inhaled, the fungus develops into 30-60 micron diameter spherules that are filled with 3-5 micron diameter endospores. The large spherules then release the endospores that continue the infection; microscopic identification of these endospores in pus or tissue confirms the diagnosis.
Photomicrographic picture of Coccidioides immitis fungal organism
Picture of Coccidioides immitis fungal organism
Pictures of Coccidioides immitis and lung X-rays can be seen in the first and third Web sites listed below.